THE ARISING · Longevity & Healthspan
Gene SRSF1 Made Aged Cells Look Younger; Linked to Longer Mouse Life
Turning up a single gene made aged human skin cells look and behave more like young ones, and in old mice it was linked to slower decline and a longer median life, according to a new study in Nature Aging. The lifespan finding is an association, not proof that the gene extends life, and the mouse groups were small.
This is early evidence. The work combines experiments in cultured human cells with tests in worms and mice. The mouse lifespan result came from small groups of 9 to 10 animals each. It is not a human trial, and nothing here shows a benefit for people.
The gene is SRSF1. It makes a protein that helps process RNA, the working copies of genes that cells read to build proteins. Plesa, Jung and colleagues first built a "transcriptomic age" predictor in human fibroblasts, a common type of skin cell. The predictor reads which genes are switched on and off and estimates how old the cells are.
They then ran a screen. They added many different genes to aged cells using a cDNA overexpression approach, and checked which ones shifted the cells toward a younger gene-activity pattern. SRSF1 came out as the standout.
Why does this matter? Earlier attempts to turn back cellular age used Yamanaka factors, a set of genes that can reset cells. According to the paper, toxicity and efficacy concerns limit their use in living animals. The authors report that SRSF1 produced youthful gene-activity patterns without the cells losing their identity. A skin cell stayed a skin cell.
In cultured cells, switching on SRSF1 reduced senescence, which is when cells stop dividing and linger in a damaged state. It also reduced proteostatic stress, meaning strain on the cell's system for handling proteins, and inflammatory signaling.
In aged mice, inducible SRSF1 expression reduced frailty progression by 44%. It was also associated with a 14% longer median lifespan. Median lifespan is the age by which half the animals have died. With 9 to 10 mice per group, chance can play a large role. This is the weakest part of the argument.
So we cannot say how the gene was delivered, how much was used, whether results differed between male and female mice, or whether there were side effects.
For you
For personal health, our reading is cautious: this study gives no basis for splicingrelated supplements or tests today. Cells in a dish and mice are a long way from a safe, proven treatment for people. Any therapy would also need a way to deliver the gene safely and at the right dose.
The authors call SRSF1 "a promising geroprotective target", meaning a possible route to protecting against aging. That is a reasonable description of where things stand. What to watch next: larger animal studies, independent replication, and the first safety data on any approach that changes SRSF1 activity.
Menopause Hormone Therapy Linked to Greater Semaglutide Weight Loss in Midlife Women Falling Cardiolipin Levels May Explain Why Aging Muscles Lose Power Swedish 47-Year Study: Aerobic Fitness and Endurance Peak Between 26 and 36 Gene SRSF1 Made Aged Cells Look Younger; Linked to Longer Mouse Life Scans of 100,000 Patients Link Active Brown Fat to Better Metabolic Health